Results 71 to 80 of about 84,160 (241)

Mashups and CB2

open access: yes, 2006
There's a regular monthly meeting in Cambridge on Thursdays in the Internet cafe called CB2. Organised with enormous energy by Rufus Pollock – see the Open Knowledge Foundation link. Mostly geeks, we have a common theme of wanting to liberate knowledge.
openaire   +1 more source

Modern pollen rain of an upland area: implications of pollen dispersal for interpreting palaeoenvironmental records

open access: yesBoreas, EarlyView.
A long‐term perspective on landscape evolution is critical for understanding past land‐use activity, land cover–climate feedbacks and, notably, for establishing a factual basis for conservation. Fossil pollen analysis provides a means to achieve this. Biases pertaining to pollen productivity, pollination processes and basin size, however, mean there is
Helen Essell, Gill Plunkett
wiley   +1 more source

Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply

open access: yesCell Death and Disease, 2021
In glucocorticoid (GC)-induced osteonecrosis of the femoral head (ONFH), downregulated osteogenic ability and damaged blood supply are two key pathogenic mechanisms.
Houyi Sun   +12 more
doaj   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

open access: yesBritish Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli   +7 more
wiley   +1 more source

CB2-GFP expression in the hippocampus of WT and CB2-GFP mice.

open access: yes, 2015
Immunohistochemical analysis of GFP expression in the brain of CB2-GFPTg mice. CB2-GFPtg mice show GFP expression in the hippocampus (a, right) which is not present in WT mice (a, left) (scale bar = 250 μm).
Anne-Caroline Schmöle (800137)   +9 more
core   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

Role of Type 2 Cannabinoid Receptor (CB2) in Atherosclerosis.

open access: yes, 2011
Atherosclerosis is a macrophage-dominated nonresolving inflammatory disease of the arterial wall. Macrophage processes, including apoptosis, influence lesion development in atherosclerosis.
Netherland, Courtney Denise
core   +1 more source

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade   +7 more
wiley   +1 more source

CB2 cannabinoid receptor as potential target against Alzheimer’s disease

open access: yesFrontiers in Neuroscience, 2016
The CB2 receptor is one of the components of the endogenous cannabinoid system, a complex network of signaling molecules and receptors involved in the homeostatic control of several physiological functions.
Ester eAso, Isidro eFerrer
doaj   +1 more source

The ongoing oleoylethanolamide story: Therapeutic implications in the control of obesity and its comorbidities

open access: yesBritish Journal of Pharmacology, EarlyView.
The global burden of obesity continues to rise, demanding effective pharmacological strategies for individuals in whom prevention alone is insufficient. Recent incretin‐based and multi‐agonist therapies have delivered unprecedented weight loss, demonstrating that the simultaneous modulation of multiple metabolic pathways can optimize body weight ...
Marzia Friuli   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy